Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Leurs

Showing results (131-140 of 141) with videos related to

Pageof 15
Sort By:
Journal of Internal Medicine|March 12, 2002
Oral oestradiol/trimegestone replacement reduces procarboxypeptidase U (TAFI): a randomized, placebo- controlled, 12-week study in early postmenopausal womenM S Post, D F Hendriks, M J Van Der Mooren, et al.
Journal of Medicinal Chemistry|April 10, 1999
Characterization of the binding site of the histamine H3 receptor. 1. Various approaches to the synthesis of 2-(1H-imidazol-4-yl)cyclopropylamine and histaminergic activity of (1R,2R)- and (1S,2S)-2-(1H-imidazol-4-yl)-cyclopropylamineI J De Esch, R C Vollinga, K Goubitz, et al.
The Journal of Investigative Dermatology|May 8, 1999
Human IP-9: A keratinocyte-derived high affinity CXC-chemokine ligand for the IP-10/Mig receptor (CXCR3)C P Tensen, J Flier, E M Van Der Raaij-Helmer, et al.
Journal of Medicinal Chemistry|May 18, 2001
Development of a pharmacophore model for histamine H3 receptor antagonists, using the newly developed molecular modeling program SLATEI J De Esch, J E Mills, T D Perkins, et al.
Nuclear Medicine and Biology|December 10, 1999
Radiosynthesis and biodistribution of 123I-labeled antagonists of the histamine H3 receptor as potential SPECT ligandsA D Windhorst, H Timmerman, R P Klok, et al.
Molecular Diversity|January 13, 2006
Efficient library synthesis of imidazoles using a multicomponent reaction and microwave irradiationE Gelens, F J J De Kanter, R F Schmitz, et al.
British Journal of Pharmacology|January 26, 2013
Design and pharmacological characterization of VUF14480, a covalent partial agonist that interacts with cysteine 98(3.36) of the human histamine H₄ receptorS Nijmeijer, H Engelhardt, S Schultes, et al.
British Journal of Pharmacology|November 6, 2012
Inhibition of CXCR3-mediated chemotaxis by the human chemokine receptor-like protein CCX-CKRJ Vinet, M van Zwam, I M Dijkstra, et al.
European Journal of Medicinal Chemistry|November 27, 2018
Structure-based exploration and pharmacological evaluation of N-substituted piperidin-4-yl-methanamine CXCR4 chemokine receptor antagonistsI Adlere, S Sun, A Zarca, et al.
British Journal of Pharmacology|November 23, 2012
Identification and profiling of CXCR3-CXCR4 chemokine receptor heteromer complexesA O Watts, M M H van Lipzig, W C Jaeger, et al.
Pageof 15

Showing results (131-140 of 141) with videos related to

Sort By:
Pageof 15
Journal of Internal Medicine|March 12, 2002
Oral oestradiol/trimegestone replacement reduces procarboxypeptidase U (TAFI): a randomized, placebo- controlled, 12-week study in early postmenopausal womenM S Post, D F Hendriks, M J Van Der Mooren, et al.
Journal of Medicinal Chemistry|April 10, 1999
Characterization of the binding site of the histamine H3 receptor. 1. Various approaches to the synthesis of 2-(1H-imidazol-4-yl)cyclopropylamine and histaminergic activity of (1R,2R)- and (1S,2S)-2-(1H-imidazol-4-yl)-cyclopropylamineI J De Esch, R C Vollinga, K Goubitz, et al.
The Journal of Investigative Dermatology|May 8, 1999
Human IP-9: A keratinocyte-derived high affinity CXC-chemokine ligand for the IP-10/Mig receptor (CXCR3)C P Tensen, J Flier, E M Van Der Raaij-Helmer, et al.
Journal of Medicinal Chemistry|May 18, 2001
Development of a pharmacophore model for histamine H3 receptor antagonists, using the newly developed molecular modeling program SLATEI J De Esch, J E Mills, T D Perkins, et al.
Nuclear Medicine and Biology|December 10, 1999
Radiosynthesis and biodistribution of 123I-labeled antagonists of the histamine H3 receptor as potential SPECT ligandsA D Windhorst, H Timmerman, R P Klok, et al.
Molecular Diversity|January 13, 2006
Efficient library synthesis of imidazoles using a multicomponent reaction and microwave irradiationE Gelens, F J J De Kanter, R F Schmitz, et al.
British Journal of Pharmacology|January 26, 2013
Design and pharmacological characterization of VUF14480, a covalent partial agonist that interacts with cysteine 98(3.36) of the human histamine H₄ receptorS Nijmeijer, H Engelhardt, S Schultes, et al.
British Journal of Pharmacology|November 6, 2012
Inhibition of CXCR3-mediated chemotaxis by the human chemokine receptor-like protein CCX-CKRJ Vinet, M van Zwam, I M Dijkstra, et al.
European Journal of Medicinal Chemistry|November 27, 2018
Structure-based exploration and pharmacological evaluation of N-substituted piperidin-4-yl-methanamine CXCR4 chemokine receptor antagonistsI Adlere, S Sun, A Zarca, et al.
British Journal of Pharmacology|November 23, 2012
Identification and profiling of CXCR3-CXCR4 chemokine receptor heteromer complexesA O Watts, M M H van Lipzig, W C Jaeger, et al.
Pageof 15